agnos.is Forums

Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

Large pharma drug licensing from China hits high at 28% in 2024

World News

1 Posts 1 Posters 0 Views

S This user is from outside of this forum
S This user is from outside of this forum
[email protected]

wrote on last edited by

#1
- The total deal value of US licensing of innovator drug candidates from Chinese biopharma companies has surged 280% since 2020.
- drug licensing agreements involving Chinese biopharma licensors has surged 66%, from $16.6 billion in 2023 to $41.5 billion in 2024
1 Reply Last reply
1
0
System shared this topic on

System shared this topic on